Kiyoshi Furukawa Selected Research

N- acetylgalactosaminyl- 1- 4- N- acetylglucosamine

1/2022	Biosynthesis and Biological Significances of LacdiNAc Group on N- and O-Glycans in Human Cancer Cells.
1/2020	LacdiNAcylation of N-glycans in MDA-MB-231 human breast cancer cells results in changes in morphological appearance and adhesive properties of the cells.
5/2015	Enhanced expression of the β4-N-acetylgalactosaminyltransferase 4 gene impairs tumor growth of human breast cancer cells.
1/2014	Expression of LacdiNAc groups on N-glycans among human tumors is complex.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kiyoshi Furukawa Research Topics

Disease

10	Neoplasms (Cancer) 01/2022 - 09/2004
4	Breast Neoplasms (Breast Cancer) 01/2022 - 07/2003
3	Neuroblastoma 01/2014 - 02/2004
2	Neoplasm Metastasis (Metastasis) 01/2012 - 06/2005
2	Alzheimer Disease (Alzheimer's Disease) 12/2006 - 03/2006
2	Carcinoma (Carcinomatosis) 09/2004 - 07/2003
1	COVID-19 01/2022
1	Prostatic Neoplasms (Prostate Cancer) 01/2022
1	Hepatocellular Carcinoma (Hepatoma) 01/2015
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2014
1	Infections 01/2014
1	Substance Withdrawal Syndrome (Withdrawal Symptoms) 08/2009
1	Body Weight (Weight, Body) 08/2009
1	Adenocarcinoma 06/2005
1	Glioma (Gliomas) 08/2004
1	Adenocarcinoma of Lung 06/2004
1	Intestinal Obstruction (Obstruction, Intestinal) 03/2003
1	Pathologic Constriction (Stenosis) 03/2003
1	Exostoses 04/2002

Drug/Important Bio-Agent (IBA)

5	OligosaccharidesIBA 09/2007 - 07/2003
4	Polysaccharides (Glycans)IBA 01/2022 - 09/2004
4	Membrane Glycoproteins (Membrane Glycoprotein)IBA 01/2022 - 07/2003
4	Proteins (Proteins, Gene)FDA Link 01/2022 - 07/2003
4	N- acetylgalactosaminyl- 1- 4- N- acetylglucosamineIBA 01/2022 - 01/2014
4	Biological ProductsIBA 01/2022 - 04/2002
4	DisaccharidesIBA 01/2020 - 07/2003
4	LectinsIBA 06/2005 - 07/2003
3	Complementary DNA (cDNA)IBA 05/2015 - 09/2004
2	N- benzyl- N- ethyl- 2- (7,8- dihydro- 7- methyl- 8- oxo- 2- phenyl- 9H- purin- 9- yl)acetamideIBA 08/2009 - 08/2004
2	beta-1,4-galactosyltransferase VIBA 09/2007 - 09/2004
2	N-Acetyllactosamine SynthaseIBA 09/2007 - 09/2004
2	Presenilin-1IBA 12/2006 - 03/2006
1	Glycoproteins (Glycoprotein)IBA 01/2022
1	Disinfectants (Biocides)IBA 01/2022
1	Sepharose (Agarose)IBA 06/2014
1	GelsIBA 06/2014
1	Blood Group Antigens (Blood Groups)IBA 01/2014
1	GlycosyltransferasesIBA 01/2012
1	Transcription Factors (Transcription Factor)IBA 01/2012
1	Anti-Anxiety Agents (Anxiolytics)IBA 08/2009
1	Diazepam (Valium)FDA LinkGeneric 08/2009
1	LigandsIBA 08/2009
1	Protein Kinase CIBA 06/2005
1	AgglutininsIBA 06/2005
1	Fibronectins (Fibronectin)IBA 06/2005
1	Membrane Proteins (Integral Membrane Proteins)IBA 06/2005
1	PhytohemagglutininsIBA 06/2005
1	StaurosporineIBA 06/2005
1	EnzymesIBA 09/2004
1	Sp1 Transcription FactorIBA 09/2004
1	GABA-A Receptors (GABA(A) Receptor)IBA 08/2004
1	Transforming Growth Factor beta1 (TGF beta 1)IBA 06/2004
1	AcetylglucosamineIBA 02/2004
1	wisteria lectinIBA 07/2003
1	AcetylgalactosamineIBA 07/2003

Therapy/Procedure

2	Therapeutics 01/2015 - 01/2012
1	Aftercare (After-Treatment) 06/2005
1	Laparotomy 03/2003
1	Conservative Treatment 03/2003